Related Experiment Video
Updated: Sep 4, 2025

Study of Protein-protein Interactions in Autophagy Research
Published on: September 9, 2017
Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects
Raquel Gomez-Sintes1,2,3, Qisheng Xin1,2,4, Juan Ignacio Jimenez-Loygorri3
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Abstract:
Chaperone-mediated autophagy activity, essential in the cellular defense against proteotoxicity, declines with age, and preventing this decline in experimental genetic models has proven beneficial. Here, we have identified the mechanism of action of selective chaperone-mediated autophagy activators previously developed by our group and have leveraged that information to generate orally bioavailable chaperone-mediated autophagy activators with favorable brain exposure. Chaperone-mediated autophagy activating molecules stabilize the interaction between retinoic acid receptor alpha - a known endogenous inhibitor of chaperone-mediated autophagy - and its co-repressor, nuclear receptor corepressor 1, resulting in changes of a discrete subset of the retinoic acid receptor alpha transcriptional program that leads to selective chaperone-mediated autophagy activation. Chaperone-mediated autophagy activators molecules activate this pathway in vivo and ameliorate retinal degeneration in a retinitis pigmentosa mouse model. Our findings reveal a mechanism for pharmacological targeting of chaperone-mediated autophagy activation and suggest a therapeutic strategy for retinal degeneration.
Insights
Scientists developed new drugs that activate chaperone-mediated autophagy, a cellular process that declines with age. These drugs show promise for treating retinal degeneration by restoring this vital cellular defense mechanism.
Area of Science:
- Cellular Biology
- Neuroscience
- Pharmacology
Background:
- Chaperone-mediated autophagy (CMA) is crucial for cellular defense against protein aggregation and declines with aging.
- Restoring CMA function has shown therapeutic benefits in genetic models.
Purpose of the Study:
- To elucidate the mechanism of action for selective CMA activators.
- To develop orally bioavailable CMA activators with brain penetration for therapeutic applications.
Main Methods:
- Investigated the molecular mechanism of previously developed CMA activators.
- Generated novel orally bioavailable CMA activators.
- Assessed in vivo efficacy in a retinitis pigmentosa mouse model.
Main Results:
- Identified that CMA activators stabilize the interaction between retinoic acid receptor alpha (a CMA inhibitor) and its co-repressor.
- Demonstrated that this stabilization leads to selective CMA activation.
- Showed in vivo activation of CMA and amelioration of retinal degeneration in a mouse model.
Conclusions:
- Revealed a novel mechanism for pharmacologically targeting CMA activation.
- Established a potential therapeutic strategy for retinal degeneration by activating CMA.
More Related Videos
08:33Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
05:03Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Export of Misfolded Proteins out of the ER
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Unfolded Protein Response
Regulation of the Unfolded Protein Response